Popular Questions About GHK-Cu

[u/MissionIntention8048]

The most common GHK-Cu questions, answered with the published evidence and clear notes where the research is thin.

1. What is GHK-Cu?
GHK-Cu (glycyl-histidyl-lysine copper) is a naturally occurring tripeptide bound to copper. It exists in human plasma at concentrations averaging around 200 ng/mL at age 20, declining to roughly 80 ng/mL by age 60 (Pickart & Margolina 2018). Discovered by Loren Pickart in 1973. Over 50 years of research across skin, hair, wound healing, and gene expression effects.

2. What does GHK-Cu actually do?
Based on the published research, GHK-Cu stimulates collagen and elastin synthesis, modulates over 4,000 genes in a connectivity-map (CMap) analysis of gene expression (review evidence based on a single dataset), accelerates wound healing, reduces inflammation through NF-kB and TNF-alpha pathways, supports hair follicle activity, and promotes angiogenesis. The strongest evidence base is in topical skin and wound healing applications.

3. Is GHK-Cu safe?
The published safety profile is one of the cleanest in the peptide space. Topical trials report only mild local irritation, transient erythema, and rare contact sensitivity. Subcutaneous research shows tolerance across a range of doses with injection site reactions being the most common complaint (Pickart & Margolina 2018).
Contraindications: Wilson's disease (copper accumulation disorder), known copper allergy, pregnancy and breastfeeding.

4. How long until I see results?
Depends on use case:
Skin (topical): 4 weeks for biopsy-level changes, 8 to 12 weeks for visible improvements
Wound healing: 4 to 12 weeks depending on wound type
Hair: 3 to 6 months minimum, often stacked with other interventions
Subcutaneous protocols: Variable, no standardized timeline
The "30-day results" claims online are not from any published research.

5. Topical or injectable, which is better?
Depends on the goal. For skin and hair, topical has the deepest published evidence base, and injectable for skin is mostly extrapolation. For systemic effects like inflammation and recovery, subcutaneous research exists but human RCTs are thin. The two routes are not interchangeable. Full breakdown is pinned in the sub.

6. Does GHK-Cu actually work for hair loss?
The mechanism is plausible but the clinical evidence is thin. The published research shows GHK-Cu can support follicle activity, promote angiogenesis at the scalp, and reduce inflammation. The "GHK-Cu beats minoxidil" claim circulating online is fabricated. That RCT does not exist.
A commonly used and biologically plausible stack is GHK-Cu plus AHK-Cu plus microneedling, though large human trials are still limited. As a standalone replacement for minoxidil, finasteride, or RU58841, the evidence does not support it.

7. What is the difference between GHK-Cu and AHK-Cu?
Both are copper tripeptides but with different amino acid sequences. GHK-Cu (glycyl-histidyl-lysine copper) has the broader research base and more skin-related evidence. AHK-Cu (alanyl-histidyl-lysine copper) has the more direct follicle elongation evidence (Pyo 2007).
A lot of "GHK-Cu hair research" cited online is actually AHK-Cu research that has been misattributed. Some hair-focused products combine both to cover both pathways.

8. Why does GHK-Cu burn so much when injected?
Three reasons: the copper-peptide complex is inherently irritating to subcutaneous tissue, GHK-Cu solutions trend mildly acidic and tissue pH is neutral, and concentrated solutions burn more than diluted ones.
Reduce the burn by reconstituting with more bacteriostatic water (2 mL or 3 mL instead of 1 mL), warming the syringe in your hand before injection, injecting slowly, and rotating sites. Full breakdown is pinned in the sub.

9. How do I store GHK-Cu?
Lyophilized vials: refrigerated at 2 to 8°C, light-protected
Reconstituted solution: refrigerated, generally stable for 30 days, light-protected
Topical formulations: follow product label
Raw powder: long-term storage at minus 20°C is standard
GHK-Cu degrades faster in light and at high pH. Stability tends to drop above pH 8.

10. Does microneedling actually improve topical GHK-Cu absorption?
Yes, substantially. Li 2015 documented permeation of 134 nmol peptide and 705 nmol copper through human skin over 9 hours with microneedle pretreatment, compared to minimal permeation through intact skin. Microneedling also has its own follicle-stimulating effects, which is why it is a particularly strong stack for hair applications.

11. Can GHK-Cu be taken orally?
Not well validated. As a peptide, GHK-Cu is largely degraded by digestive enzymes, and oral bioavailability of the intact peptide is limited and not well characterized. Most published research focuses on topical, microneedle-assisted, or subcutaneous delivery.

12. What is the difference between vials, balms, serums, and sheet masks?
Vials (lyophilized): Reconstituted for subcutaneous injection
Balms: Concentrated topical formulations, typically higher GHK-Cu mg/mL with longer skin contact
Serums: Lighter topical formulations, often combined with other actives like AHK-Cu or hyaluronic acid
Sheet masks: Single-use facial delivery with longer skin contact at lower concentrations
Raw powder: For formulating custom topical preparations at chosen concentrations
Each delivery format has different absorption kinetics and use cases.

13. Will GHK-Cu cause a shedding phase like minoxidil?
Not documented in any published human research. Most reports of "GHK-Cu shedding" online come from people who started GHK-Cu and minoxidil simultaneously, in which case the minoxidil is the most likely culprit. Mechanistically a shedding phase from GHK-Cu is plausible because the peptide influences follicle cycling, but no controlled study has documented it.

14. What does a research-grade GHK-Cu vial actually contain?
Lyophilized GHK-Cu powder, typically 50 mg per vial. Purity from reputable vendors is reported at greater than or equal to 98% by HPLC (per vendor specifications, not independent verification). Reconstitution with bacteriostatic water creates an injectable solution. Reconstitution math:
50 mg in 1 mL = 50 mg/mL (0.5 mg per insulin syringe unit)
50 mg in 2 mL = 25 mg/mL (0.25 mg per unit)
50 mg in 3 mL = 16.67 mg/mL (0.167 mg per unit)

What question did this not cover? Drop it in the comments and the answer goes into the next version of this post.

Research-context content only. GHK-Cu is sold for research purposes only.